~~<i id='BA0FDE9AE2'><strike id='BA0FDE9AE2'><tt id='BA0FDE9AE2'><pre id='BA0FDE9AE2'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：hotspot 2025-09-06 03:32:35 - browse：3741

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Fatty liver disease was alleviated by Lilly’s ‘triple

leisure time

focus

Wikipedia

focus

entertainment

2:22NASA'sJamesWebbSpaceTelescoperevealsStephan'sQuintetinanewlight.Avisualgroupingoffivegalaxies,is

WSS

Some dementia cases could be undiagnosed liver disease

Commercial surrogacy can be ethical, despite pope’s claims

Do digital therapeutics have a future in medicine?

Congressmen charge Covid hearing ‘could have been an email’

Juul spent big to court Black leaders to promote its e

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

hotspot

explore

leisure time

How to save PrEP access — and even expand it

What we need to know about Arena Bioworks

At least 13 dead in Texas as scorching temps continue

'Screen and refer' systems are hurting patients

In Memoriam: Notable people who died in 2023

Time to name cancers by genetics, not organ of origin, expert says

Medicare details structure of new drug price negotiation program

Quicker fix for pulse oximeters urged during FDA public meeting

Medicare details structure of new drug price negotiation program

Novo Nordisk to expand supply of Wegovy for U.S. patients

focus

Juul spent big to court Black leaders to promote its e

Use doctors trained outside the U.S. to ease the physician shortage

Novo Nordisk to expand supply of Wegovy for U.S. patients

Apple Vision Pro: A first look at health apps on the new VR headset

A $475,000 price tag for a new cancer drug: crazy or meh?

Crowdfunding for unproven stem cell procedures spreads misinformation

Wikipedia

focus

entertainment

entertainment